Business Win in Benelux for Sphere

Sphere Medical has confirmed the first sale of its Proxima^TM blood gas monitoring system in Benelux. A system is to be permanently installed at the Universitair Ziekenhuis Brussel, a 700 bed teaching hospital conducting scientific research, which has evaluated the system during the past year.

fter the UK and Germany, Belgium is the third country in which the company has sold Proxima devices through its direct sales force. This includes Petra Maissan, Benelux Sales Manager for Sphere Medical; as a qualified Nurse Anaesthetist, Petra was able to offer in depth discussion on the clinical value of the monitor to Attendees of the NVIC (Dutch Intensive Care Society) Najaarscongres 2016 held in Veenendaal during September where the system was also shown.

Dr Wolfgang Rencken, Chief Executive Officer of Sphere Medical, said, “Proxima is an innovative product which offers better patient management during a patient’s critical period and faster and more frequent production of blood gas, electrolyte and metabolite results. We are pleased to bring Proxima to patients around Europe and report sales in three countries now. As we look ahead to the launch of Proxima 4, the opportunity to increase potential coverage from around 10% of critical care patients to 40-50% gives us optimism for the future.”